1-6 of 6
Brian W. Raden
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tyrosine Phosphorylation Enhances ITIM-Dependent Internalization of CD33, the Target for the Anti-AML Immunoconjugate, Gemtuzumab Ozogamicin.

Roland B. Walter, MD, Brian W. Raden, BS, Irwin D. Bernstein, MD, Jonathan A. Cooper, PhD
Journal: Blood
Blood (2006) 108 (11): 2581.
https://doi.org/10.1182/blood.V108.11.2581.2581
Published: 2006
Journal Articles

Lysosomal Degradation of CD33, the Target for the Anti-Leukemia Immunoconjugate, Gemtuzumab Ozogamicin: Evidence for Cbl-Mediated Monoubiquitination.

Roland B. Walter, MD, Brian W. Raden, BS, Darren M. Kamikura, PhD, Irwin D. Bernstein, MD, Jonathan A. Cooper, PhD
Journal: Blood
Blood (2005) 106 (11): 2469.
https://doi.org/10.1182/blood.V106.11.2469.2469
Published: 2005
Journal Articles

Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin–induced cytotoxicity

Roland B. Walter, Brian W. Raden, Darren M. Kamikura, Jonathan A. Cooper, Irwin D. Bernstein
Journal: Blood
Blood (2005) 105 (3): 1295–1302.
https://doi.org/10.1182/blood-2004-07-2784
Published: 2005
Journal Articles

Influence of CD33 Expression Levels and ITIM-Dependent Internalization on Gemtuzumab Ozogamicin-Induced Cytotoxicity.

Roland B. Walter, MD, Brian W. Raden, MS, Darren M. Kamikura, PhD, Jonathan A. Cooper, PhD, Irwin D. Bernstein, MD
Journal: Blood
Blood (2004) 104 (11): 1176.
https://doi.org/10.1182/blood.V104.11.1176.1176
Published: 2004
Journal Articles

The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin

Roland B. Walter, Brian W. Raden, Michelle R. Cronk, Irwin D. Bernstein, Frederick R. Appelbaum, Deborah E. Banker
Journal: Blood
Blood (2004) 103 (11): 4276–4284.
https://doi.org/10.1182/blood-2003-11-3825
Published: 2004
Journal Articles

Multidrug resistance protein attenuates gemtuzumab ozogamicin–induced cytotoxicity in acute myeloid leukemia cells

Roland B. Walter, Brian W. Raden, Tom C. Hong, David A. Flowers, Irwin D. Bernstein, Michael L. Linenberger
Journal: Blood
Blood (2003) 102 (4): 1466–1473.
https://doi.org/10.1182/blood-2003-02-0396
Published: 2003